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Abstract
Introduction: Laryngeal tuberculosis used to be a common complication in advanced pulmonary
tuberculosis. However, it has become a rare occurrence in developed countries since the
introduction of antituberculous agents. Moreover, the pattern of the disease has changed over the
years. Nowadays, it more closely resembles a laryngeal carcinoma than any other laryngeal illness.
Case presentation: We describe the case of a 50-year-old Caucasian man who presented with
the clinical picture of laryngeal cancer, but which turned out to be tuberculosis. We illustrate the
difficulty of recognizing laryngeal tuberculosis both clinically and even with radiological examination.
Conclusion: Although laryngeal tuberculosis is uncommon, especially in developed countries, it
still occurs and should be considered as a differential diagnosis in any laryngeal disease, in particular
in the case of a laryngeal carcinoma.
Introduction
Tuberculosis (TB) was a highly prevalent disease in
humans for many decades until the early 1900s and is still
the main cause of death in some parts of the world. In
2007, approximately 13.7 million people contracted TB
and 1.8 million died as a result of the disease. A total of
68% of newly infected people were of Asian or African ori-
gin, whereas ethnic Europeans only made up 5% of global
TB cases [1].
After the introduction of antituberculous agents, preven-
tive programs and better socioeconomic conditions, TB
incidence decreased dramatically up until the 1980s [1-4].
In subsequent years, however, the epidemic spread of
HIV, illicit drug use and the emergence of multi-drug-
resistant mycobacteria have resulted in a resurgence of TB.
In 1993, it became the leading cause of death from a sin-
gle infectious agent. Increased numbers of migration and
travelling to and from less-developed countries also con-
tributed to the worldwide spread of TB [3-7]. The inci-
dence of TB continues to increase (122 per 100,000 in
1997 versus 142 per 100,000 in 2007), despite the fact
that it has stabilized or decreased in over 70% of coun-
tries. A minority of underdeveloped, mainly African,
countries has been the major contributor to the global
incidence growth [1]. The change in TB incidence over
time for underdeveloped, developing and developed
countries is shown in Figure 1.
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Laryngeal TB used to be a common complication of pul-
monary TB. At the start of the 20th century it affected 25-
30% of all infected patients. Today, laryngeal TB occurs in
only 1% of cases [4,8-10]. The pattern and clinical symp-
toms of laryngeal TB have also changed. Currently, it has
many similarities to laryngeal carcinoma [4,5,7,11].
We present a case of laryngeal TB in a Caucasian man who
had characteristic symptoms of a supraglottic laryngeal
carcinoma without any clinical pulmonary manifesta-
tions. The purpose of this case report and review of the lit-
erature is to raise awareness of this rare but prevailing
disease.
Case presentation
A 50-year-old Caucasian man was referred to our
otolaryngology outpatient clinic with a two-month his-
tory of persistent dysphonia, dysphagia and odynophagia
with radiating pain to the right ear. In addition, he had
experienced recurrent aspiration of liquids and had lost 3
kg in weight. His prior medical history was unremarkable.
He had been a tobacco smoker for 40 years, but there was
no history of alcohol abuse. Laryngoscopy revealed an
ulcer on the right false vocal cord with an extension to the
epiglottis. Oedema and decreased mobility of the right
true vocal cord were observed as well as the diffused swell-
ing of both arytenoids. There was no lymphadenopathy as
confirmed by an ultrasound sonography of the neck. The
initial anteroposterior chest X-ray, being part of the rou-
tine diagnostic work-up, showed miliary nodules that
were predominantly bilaterally distributed in the upper
parts of the lung parenchyma (Figure 2A). The axial con-
trast-enhanced computed tomography (CT) scan of the
neck demonstrated an enhanced mass in the right false
vocal cord with an obliteration of the paraglottic fat,
extending into the anterior commissure and cranially,
obliterating the right piriform sinus (Figure 2B). A full
blood count and electrolytes were within normal limits.
Direct laryngoscopy performed under general anaesthesia
revealed a tumour covering the entire right, false vocal
cord with an extension to the laryngeal side of the epiglot-
tis without affecting the glottis. The tumour was clinically
staged as a T3N0 supraglottic laryngeal carcinoma.
TB incidence per 100,000 inhabitants for developed, develop- ing and underdeveloped countries in the past decade Figure 1
TB incidence per 100,000 inhabitants for developed, 
developing and underdeveloped countries in the past 
decade. Based on the Human Development Index (HDI) and 
tuberculosis (TB) incidence per country between 1997 and 
2007 [1]. The graph summarizes data of 172 countries: 73 
developed countries (HDI >0.8), 73 developing countries 
(HDI 0.5-0.8) and 26 underdeveloped countries (HDI <0.5).
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Radiography Figure 2
Radiography. (A) Initial antero-posterior chest X-ray. Miliary nodules predominantly bilaterally distributed in the upper parts 
of the lung parenchyma. (B) Axial contrast-enhanced computed tomography image of the neck: enhanced mass (arrows) in the 
false vocal cord which extends into the anterior commissure and obliteration of the paraglottic fat (arrowhead). (C) Axial high 
resolution computed tomography image of the chest: diffusely distributed interstitial nodular alterations with formation of cen-
tral cavities (arrows).Journal of Medical Case Reports 2009, 3:9288 http://www.jmedicalcasereports.com/content/3/1/9288
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Histopathological examination, however, revealed a necr-
otising granulomatous inflammation without signs of
malignancy (Figure 3A, C, D). Ziehl-Neelsen staining of
the tissue biopsies and sputum revealed acid-fast bacilli
(Figure 3B). Sputum culture turned out to be positive for
Mycobacterium tuberculosis. An additional axial high reso-
lution CT scan of the chest demonstrated diffuse intersti-
tial nodular alterations with the formation of central
cavities, indicative of pulmonary TB (Figure 2C).
Treatment commenced with isoniazid 300 mg/day,
rifampicin 600 mg/day, pyrizinamide 1500 mg/day and
ethambutol 1400 mg/day for a period of 2 months. Spu-
tum cultures became negative after a 3-month follow up.
Because of cavity formations, as revealed by the chest CT,
treatment with isoniazid and rifampicin was prolonged
for another 3 months.
Because the patient was discharged from hospital a day
after a direct laryngoscopy, there was ample opportunity
for the patient to infect his healthcare providers. Contact
surveys revealed that the resident and nurse, who both
assisted in performing the laryngoscopy, two of the
patient's relatives and two of his friends all tested positive
in their purified protein derivative tests (PPD). They were
all preventively treated with tuberculostatics.
Discussion
Extra pulmonary TB in the head and neck region most fre-
quently occurs in the cervical lymph nodes (>90%), fol-
lowed by the larynx (2% to 6%) [8,9]. Involvement of the
temporal bone, sinonasal cavity, eye, pharynx, thyroid
and skull base are even less frequently observed [4,8,9].
The characteristics of laryngeal TB have changed over the
years and it has become a challenge for otolaryngologists
to distinguish this disease from others. In the past, laryn-
geal TB typically affected young people in the second or
third decade of life with advanced pulmonary TB. Symp-
toms were cough, haemoptysis, fever, weight loss and
night sweats. An ulcerative, granulomatous lesion was
generally positioned on the posterior part of the larynx
due to accumulation of sputum in the arytenoid region in
bed-bound patients. Today, laryngeal TB mainly involves
people in their 50 s or 60 s presenting first and foremost
with hoarseness (80% to 100%). Other symptoms are
odynophagia (50% to 67%) and to a lesser extent, dys-
phagia, dyspnoea, stridor, cough and haemoptysis.
Systemic symptoms have become rare [2,4-7,9,11]. Laryn-
geal TB can involve all parts of the larynx and there is no
longer an unmistakable association with pulmonary TB.
The larynx becomes infected either by a direct spread from
the lungs, or by a haematogenous spread from sites other
than the lungs [5,11,12]. The former mechanism is most
common and probably relevant for the patient in our case.
In the case of a haematogenous spread, there is no evi-
dence of pulmonary disease [3,7,9]. The distinction
between laryngeal TB and chronic laryngitis or laryngeal
carcinoma in particular has become difficult.
Odynophagia is described as an important discriminating
symptom, since it is considered rare in laryngeal cancer
[2,5-7,11]. Yet, from experience we know that painful dys-
phagia is a well-known symptom reported among
patients suffering from a supraglottic laryngeal carci-
noma. In a physical examination, the true vocal cords are
most frequently affected by laryngeal TB, followed by the
epiglottis, false vocal cords and ventricles, arytenoids, pos-
terior commissure and the subglottic area [4,7,12]. Laryn-
geal TB can manifest as oedema, hyperaemia or ulcerative
lesions, but can also present as a nodule, an exophytic
mass or obliteration of an anatomical structure [12]. Aside
from chronic laryngitis and laryngeal carcinoma, these
various presentations give rise to a comprehensive differ-
ential diagnosis including cat-scratch disease, syphilis,
sarcoidosis, Wegener's granulomatosis and fungal infec-
tions [8]. Since pathognomonic characteristics indicative
of laryngeal TB do not exist and the fact that it is an
uncommon disease in industrialised countries, the infec-
tion is easily mistaken for the more frequently occurring
laryngeal carcinoma [3,6,8]. Our patient had a long-
standing history of heavy smoking, and had symptoms of
hoarseness and odynophagia. Laryngoscopy revealed an
oedematous tumour with decreased mobility of the vocal
cord. The clinical signs, supported by the findings on the
initial CT scan of the larynx, led us to the diagnosis of a
Biopsy histology Figure 3
Biopsy histology. (A) Necrotising granulomatous inflam-
mation: granuloma on the left and necrosis on the right side 
of the image. (B) Red stained Mycobacterium tuberculosis in 
Ziehl-Neelsen acid fast stain. (C) Granuloma with a multinu-
cleated giant cell in the center (left side of image). (D) Over-
view of a necrotising granulomatous inflammation: 
granulomas on the left side and necrosis on the right.Publish with BioMed Central    and   every 
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laryngeal carcinoma. Laryngeal TB, however, can have the
exact same symptoms. In the majority of cases, there is an
association with pulmonary TB [2,4]. Therefore, an anom-
alous chest X-ray, if not compatible with pulmonary
metastasis, should alert the radiologist and otolaryngolo-
gist to the possibility of TB, especially when former chest
X-rays were normal.
Laboratory techniques for detecting TB infections include
histopathological tissue examinations with Ziehl-Neelsen
histochemical staining for acid-fast bacilli and identifica-
tion of M. tuberculosis by polymerase chain reaction or
bacterial culture. The latter method, although time-con-
suming, is considered the reference standard [13]. A CT of
the neck cannot definitively identify laryngeal TB since, as
in a chest X-ray, it can imitate many other diseases. Antitu-
berculous agents are the primary treatment for laryngeal
TB. The improvement of dysphagia and resolving of cav-
ernous lung lesions are expected to occur within several
weeks [6,12,14,15]. If not treated early, laryngeal TB can
result in (sub)glottic stenosis, muscular involvement and
vocal cord paralysis when the cricoarytenoid joint or
recurrent laryngeal nerve are invaded [5,12].
Conclusion
Laryngeal TB is uncommon, particularly in developed
countries, but it still occurs. There are no pathognomonic
features indicative of this disease and it can mimic many
others. If misdiagnosed, laryngeal TB can have severe con-
sequences for the patient and anyone he comes into con-
tact with. Therefore, it is important for otolaryngologists
to recognise the altered pattern of laryngeal TB and to be
familiar with its resemblance to malignancy. This is not
only in view of clinical symptoms, but also from a radio-
logical point of view. Laryngeal TB should be considered
as a differential diagnosis in any laryngeal disease and in
particular in the case of a laryngeal carcinoma.
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